“DDMAC Watch” Challenges FDA Authority Over Sales Reps’ Statements
Executive Summary
The Washington Legal Foundation is questioning FDA's legal authority to regulate oral statements by sales representatives
You may also be interested in...
DDMAC's Latest Exhibit Hall Citation Is Vectibix; Firms Try Multiple Ways To Avoid FDA At Trade Shows
Amgen rep's description of KRAS information as predictive of response to the colorectal cancer drug during a ASHP meeting draws a notice of violation from FDA.
WLF Questions Ad Division Allegations; “DDMAC Watch” Starts With Strattera
Direct-to-consumer advertising does not endanger the public health because access to prescription drugs is controlled by physicians, not the public, the Washington Legal Foundation's new advertising regulation watchdog group suggests
Booth Promotion Compliance Improving, FDA Says; Gilead Viread Cited At ICAAC
FDA's Division of Drug Marketing, Advertising & Communications believes that compliance with promotional regulations in the exhibit booth setting is improving